Commentary

Investing in growth: Oak HC/FT backs Infusion for Health, FTV brings Vagaro's valuation to $1bn

Oak HC/FT backs Infusion for Health and FTV investment values Vagaro at $1bn.

Rewiring healthcare: value-based care incites groundswell of investment; GTCR buys Cisive

Value-based care emerges as must-have for investors,

The four reasons private equity must “stage” assets

Few sponsors take a final look at what can be improved operationally and financially to generate stronger returns as they prepare to sell.

Carlyle joins Warburg as investor in Duravant, Linden preps 2022 sale of Evolution Research Group

Busted processes haunt investors in crowded M&A market.

T. Rowe Price agrees to acquire Oak Hill Advisors, NewSpring Capital runs process to more time, capital for Verisma

T. Rowe Price agreed to acquire Oak Hill Advisors for up to $4.2 billion.

Centerbridge, Vistria seek minority stake sale of Sevita ahead of GP-led deal, Bain Capital invests in Cardurion Pharmaceuticals and Gluware

Bain Capital makes two investments.

The booming e-sports industry nears an inflection point

If it surprises you that video game contests are attracting as many viewers as the Super Bowl on a global scale, you probably haven’t been paying close attention to the dramatic rise of e-sports in recent years.

Shore Capital explores sale of Mission Veterinary Partners, two execs from Shamrock raising debut fund

Shore Capital Partners is considering a sale of Mission Veterinary Partners and Coral Tree targets $350 million for inaugural fund.

Wellspring clinches third home care deal with Caring Brands, H&F and EQT jointly bid for Zooplus, VSS makes 3x-plus on Coretelligent

Wellspring acquires Caring Brands while H&F and EQT jointly pursue Zooplus.

EyeCare Partners inks $600m add-on, Partners Group bans 'deal' terminology, Blue Wolf carves out CIVCO Radiotherapy from Roper

Partners' EyeCare Partners buys Revelstoke's CVP while Blue Wolf buys Roper's radiotherapy arm.